Latham Recognized With Seven LMG Life Sciences EMEA Awards 2024
Latham & Watkins received an array of awards at the LMG Life Sciences Awards EMEA 2024. Regarded as one of the industry’s leading awards programs in the region, the event recognizes leading law firms and lawyers from across Europe and the Middle East and celebrates their success in the life sciences industry.
Latham earned seven awards at this year’s event, including:
- M&A Firm of the Year
- Germany Firm of the Year
- Corporate Lawyer of the Year: Robbie McLaren, London partner and Global Vice Chair of Latham’s Healthcare & Life Sciences Industry Group
- Impact Case of the Year: Stelara® litigation
- Impact Deal of the Year: Ironwood’s US$1 billion acquisition of VectivBio
- Impact Deal of the Year: Abcam’s US$5.7 billion sale to Danaher
- Impact Deal of the Year: EQT Private Equity’s sale of LimaCorporate to Enovis Corporation
LMG Life Sciences also shortlisted Latham in other categories, including Corporate Firm of the Year, Venture Capital Firm of the Year, as well as Firm of the Year for Belgium, France, Italy, MENA, The Netherlands, the Nordics, Switzerland, and the UK. Brussels partner Eveline Van Keymeulen was shortlisted for Regulatory Advisor of the Year and London associate Samantha Peacock was shortlisted for Financial Rising Star.